Literature DB >> 9862374

Responses to human rhinovirus in CD45 T cell subsets isolated from tonsil.

S Wilamasundera1, D R Katz, B M Chain.   

Abstract

Isotypes of CD45 have been used extensively as markers of memory and naive populations of T cells in peripheral blood. In this study, T cells were isolated from human tonsil and their proliferative response against human rhinovirus was measured. Unexpectedly, equivalent responses were found among the CD4+CD45RA+ and CD4+CD45RO+ populations of T cells. This response requires MHC class II-positive antigen-presenting cells. The time course of the T cell response in vitro was that of a classical recall response, and no proliferative response to the virus could be detected in human cord blood. These results suggest that tonsils contain a significant population of CD45RA+ memory cells. The presence of this population may reflect ongoing stimulation with this common infectious agent, and the anatomical location of the T cells within the major lymphoid organ draining the naso-pharyngeal epithelial surface.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862374     DOI: 10.1002/(SICI)1521-4141(199812)28:12<4374::AID-IMMU4374>3.0.CO;2-P

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

Review 1.  Qualitative differences between naïve and memory T cells.

Authors:  Marion Berard; David F Tough
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

2.  Placental expression of CD100, CD72 and CD45 is dysregulated in human miscarriage.

Authors:  Teresa Lorenzi; Angelo Turi; Maria Lorenzi; Francesca Paolinelli; Francesca Mancioli; Lucia La Sala; Manrico Morroni; Pasquapina Ciarmela; Angelo Mantovani; Andrea Luigi Tranquilli; Mario Castellucci; Daniela Marzioni
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

Review 3.  Mechanisms of rhinovirus-induced asthma.

Authors:  Nikolaos G Papadopoulos; Alberto Papi; Stelios Psarras; Sebastian L Johnston
Journal:  Paediatr Respir Rev       Date:  2004-09       Impact factor: 2.726

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.